Cost of Illness Analysis of Human Immuno Deficiency Virus/ACQUIRED Immuno Deficiency Syndrome (HIV/AIDS) in a Developing Economy.

Simple item page
dc.contributor.authorGiwa, A
dc.contributor.authorGiwa, H.B.F
dc.contributor.authorJamiu, M.O
dc.date.accessioned2019-10-22T15:17:37Z
dc.date.available2019-10-22T15:17:37Z
dc.date.issued2018
dc.description.abstractBackground: Highly Active Antiretroviral Therapy is for lifetime of the patients from time of diagnosis of HIV/AIDS. This translates into a substantial cost in drug therapy to the patients, government and donor agencies. Objective: To conduct cost of illness analysis of HIV/AIDS in a Developing Economy in 2016. Methods: A one-year retrospective review of 2560 prescriptions of 396 HIV/AIDS patients' case notes from January to December, 2016 obtained by systematic random sampling from 4800 case-notes of subjects that participated in this study was conducted. Sampling Interval =10 A data collection form was designed and used to collect data generated from the selected case notes. Cost of Illness was determined by prevalence rate method, using direct costs only. Results: The annual cost of illness for the 396 HIV/AIDS patients on highly active antiretroviral therapy was ?40,674,760 (US$127,108.3) with drug, diagnostic/monitoring tests, transport, care/support and personnel cost components of ?25,479,760; US$79,624.3 (62.64%), ?7,200,000; US$22,500 (17.71%), ?1,440,000; US$4,500(3.54%), ?2,880,000; US$9,000 (7.08%) and ?3,675,000; US$11484 (9.03%) respectively. The annual average cost of illness of HIV/AIDS was ?102,714.04 (US$320.98) Conclusion: The annual average cost of illness of HIV/AIDS represent 97% of annual per capita income. This is enormous. The Annual National cost of illness for HIV/AIDS in Nigeria, a developing economy may be about N590 billion annuallyen_US
dc.description.sponsorshipSelfen_US
dc.identifier.citationGiwa A, Giwa HBF, Jamiu MO (2018): Cost of Illness Analysis of Human Immuno Deficiency Virus/ACQUIRED Immuno Deficiency Syndrome (HIV/AIDS) in a Developing Economy. West African Journal of Pharmacy. 29(2); 44-52, Published by West African Postgraduate College of Pharmacy.en_US
dc.identifier.issn2384-6674
dc.identifier.urihttp://hdl.handle.net/123456789/3053
dc.language.isoenen_US
dc.publisherWest African Postgraduate College of Pharmacyen_US
dc.subjectCost of Illnessen_US
dc.subjectAnalysisen_US
dc.subjectHIV/AIDSen_US
dc.subjectDeveloping economyen_US
dc.titleCost of Illness Analysis of Human Immuno Deficiency Virus/ACQUIRED Immuno Deficiency Syndrome (HIV/AIDS) in a Developing Economy.en_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Cost of Illness Analysis of HIV-AIDS WAJP.pdf
Size:
164.28 KB
Format:
Adobe Portable Document Format
Description:
Cost of Illness Analysis of Human Immuno Deficiency Virus/ACQUIRED Immuno Deficiency Syndrome (HIV/AIDS) in a Developing Economy
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections